Vitamin D Receptor Polymorphisms Among the Turkish Population are Associated with Multiple Sclerosis

Abstract Multiple sclerosis (MS) is an inflammatory disease characterized by demyelination and axonal degeneration affecting the central nervous system. Among the genetic factors suggested to be associated with this disease are polymorphisms to the vitamin D receptor (VDR) gene. We tested the hypothesis that polymorphisms in the vitamin D receptor (VDR) gene are associated with MS. The aim of the study was to investigate the relationship of MS with the VDR gene Fok-I, Bsm-I and Taq-I polymorphisms among the Turkish population. This study contains 271 MS patients and 203 healthy controls. Genomic DNA was isolated from the samples and the VDR gene Fok-I, Bsm-I and Taq-I polymorphism regions were amplified by polymerase chain reaction (PCR). The PCR products were digested, and the genotypes were determined based on size of digested PCR products. Our results demonstrate associations between MS and the distribution of the VDR gene Fok-I T/T polymorphism genotype in a dominant model, VDR gene Fok-I T allele frequency, distribution of VDR gene Taq-I C/C polymorphism genotype in a dominant model and VDR gene Taq-I C allele frequency (Pearson test, p<0.05). However, there was no association between MS and the VDR gene Bsm-I polymorphisms for the genotype distribution (Pearson test, p>0.05) or allele frequency (Pearson test, p>0.05). Fok-I and Taq-I VDR gene polymorphisms are significantly associated with MS in dominant, homozygote and heterozygote inheritance models among the Turkish population.

[1]  D. Imani,et al.  Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis , 2019, BMC Neurology.

[2]  M. Sozen,et al.  The association between vitamin D receptor polymorphisms and multiple sclerosis in a Turkish population. , 2018, Multiple sclerosis and related disorders.

[3]  A. Reder,et al.  Vitamin D and Multiple Sclerosis: A Comprehensive Review , 2017, Neurology and Therapy.

[4]  A. Moghtaderi,et al.  Positive Association of Vitamin D Receptor Gene Variations with Multiple Sclerosis in South East Iranian Population , 2015, BioMed research international.

[5]  B. Kálmán,et al.  Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D–VDR Complex in Multiple Sclerosis , 2014, NeuroMolecular Medicine.

[6]  J. Benito-León,et al.  Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis , 2013, PloS one.

[7]  Jian Huang,et al.  Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case–control studies , 2012, Journal of the Neurological Sciences.

[8]  M. Hewison Vitamin D and the immune system: new perspectives on an old theme. , 2010, Endocrinology and metabolism clinics of North America.

[9]  M. Ban,et al.  Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis , 2012, Multiple sclerosis.

[10]  A. Sadovnick,et al.  Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians , 2011, Journal of the Neurological Sciences.

[11]  A. Ascherio,et al.  Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis , 2010, Multiple sclerosis.

[12]  P. Menheere,et al.  The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. , 2009, Autoimmunity reviews.

[13]  T. Dwyer,et al.  Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction , 2009, Multiple sclerosis.

[14]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[15]  R. Strange,et al.  Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis , 2008, Multiple sclerosis.

[16]  L. Pardo,et al.  Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis , 2008, Neurobiology of Disease.

[17]  C. Wolfson,et al.  Environmental risk factors in multiple sclerosis , 2008, Acta neurologica Scandinavica. Supplementum.

[18]  M. Haussler,et al.  Vitamin D Receptor: Key Roles in Bone Mineral Pathophysiology, Molecular Mechanism of Action, and Novel Nutritional Ligands , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Wolfgang Brück,et al.  The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage , 2005, Journal of Neurology.

[20]  R. Lea,et al.  VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION , 2005, Journal of neurogenetics.

[21]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[22]  T. Meehan,et al.  The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ , 2002 .

[23]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[24]  S. Kikuchi,et al.  Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles , 2000, Journal of the Neurological Sciences.

[25]  K. Miyasaka,et al.  Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese , 1999, Journal of the Neurological Sciences.

[26]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[27]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[28]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[30]  T. Fog,et al.  [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.

[31]  L. Kurland The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. , 1952, American journal of hygiene.

[32]  V. Shaygannejad,et al.  Cytokines gene expression in newly diagnosed multiple sclerosis patients. , 2015, Iranian journal of allergy, asthma, and immunology.

[33]  M. Rasaee,et al.  Modified salting‐out method: high‐yield, high‐quality genomic DNA extraction from whole blood using laundry detergent , 2005, Journal of clinical laboratory analysis.

[34]  H. Mcdevitt,et al.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. , 1995, Immunology today.